Chen Gang, Mu Lei, Zhang Xiao, Hou Shixiang, Nan Haijun
Department of Pharmaceutical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Zhongguo Zhong Yao Za Zhi. 2011 Jul;36(13):1815-20.
To investigate in vivo distribution and pharmacokinetics of ginsenoside Rb1 (Rb1), ginsenoside Rg1 (Rg1 ) and sanchinoside R1 (R1) after intratympanic administration (IT) or intravenous administration (IV) of Panax notoginseng saponions (PNS) solution, and provide a novel route for delivering traditional Chinese medicine (TCM) to the brain.
The guinea pigs were employed as experimental animal. Perilymph (PL), cerebrospinal fluid (CSF), brain tissue and plasma were collected periodically after IT and IV of PNS solution. The concentrations of Rb1, Rg1 and R1 were measured by high performance liquid chromatography (HPLC), and statistic program DAS was applied to the calculation of pharmacokinetic parameters. The self-defined weighting coefficients based on area under curve (AUC) of each component were created to obtain the holistic pharmacokinetic profiles of PNS. The integrated pharmacokinetic parameters were then calculated from non-compartmental model analysis.
Rb1, Rg1 and R1 diffused through the round window membrane into PL of the inner ear, and then transported to the brain after IT of PNS solution. However, the pharmacokinetic parameters showed significant differences between the three components. Based on the self-defined AUC weighting coefficients integration approach, the holistic pharmacokinetic profiles of PNS were obtained, from which the integrated pharmacokinetic parameters were calculated. The C(max) in CSF and brain tissues following IT were respectively 1.5 and 0.4-fold higher than those following IV. After IT, the AUC in CSF and brain tissues increased by 0.5 and 1.2 times compared with IV. Furthermore, the C(max) and AUC in plasma following IT were respectively 45.9% and 33.1% lower than those following IV.
This novel intra-cochlear administration might serve as a potential and promising alternative to TCM delivery with enhanced brain-targeted efficiency.
研究三七总皂苷(PNS)溶液经鼓室内给药(IT)或静脉给药(IV)后,人参皂苷Rb1(Rb1)、人参皂苷Rg1(Rg1)和三七皂苷R1(R1)的体内分布及药代动力学,为中药向脑内递送提供新途径。
以豚鼠为实验动物。PNS溶液经IT和IV给药后,定期收集外淋巴液(PL)、脑脊液(CSF)、脑组织和血浆。采用高效液相色谱法(HPLC)测定Rb1、Rg1和R1的浓度,并应用统计程序DAS计算药代动力学参数。基于各成分曲线下面积(AUC)创建自定义加权系数,以获得PNS的整体药代动力学特征。然后通过非房室模型分析计算综合药代动力学参数。
PNS溶液经IT给药后,Rb1、Rg1和R1通过圆窗膜扩散至内耳PL,然后转运至脑内。然而,三种成分的药代动力学参数存在显著差异。基于自定义AUC加权系数积分法,获得了PNS的整体药代动力学特征,并据此计算了综合药代动力学参数。IT给药后CSF和脑组织中的C(max)分别比IV给药后高1.5倍和0.4倍。IT给药后,CSF和脑组织中的AUC分别比IV给药后增加了0.5倍和1.2倍。此外,IT给药后血浆中的C(max)和AUC分别比IV给药后低45.9%和33.1%。
这种新型的鼓室内给药可能是一种潜在且有前景的中药递送替代方法,具有增强的脑靶向效率。